← FDA DRUG APPROVALS

FDA ANDA · ANDA200065

DOXYCYCLINE

Sponsor: IMPAX LABS INC

APPLICATION
ANDA200065
TYPE
ANDA
ORIGINAL APPROVAL
2011-02-17
LATEST ACTION
2025-03-31
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DOXYCYCLINEDiscontinued
DOXYCYCLINE EQ 150MG BASE · CAPSULE · ORAL

Approval history

2025-03-31Labeling · Supplement 18 · standardAP
2025-03-26Labeling · Supplement 14 · standardAP
2016-03-14Labeling · Supplement 9 · standardAP
2016-03-14Labeling · Supplement 7 · standardAP
2011-02-17Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →